Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow First Trust: 

Search by Ticker, Keyword or CUSIP       
 
 

Health Care Select, 25  Ticker: FGTWRX
 
Description
A unit investment trust that seeks above average capital appreciation by investing in a concentrated portfolio of leading health care companies.
 
Summary
Product Code: HC2Y25
Portfolio Status: Secondary
Initial Offer Date: 07/11/2012
Secondary Date: 10/09/2012
Portfolio Ending Date: 07/14/2014
Tax Structure: RIC
Distributions: Semi-Annual
 
Initial Offer Price: $10.0000
NAV(*): $13.4473
POP(*): $13.9278
* As of Trade Date: 05/21/2013 4:00pm ET

 Estimated Net Annual Distribution Per Unit
Estimated Net Annual Distribution Per Unit * $0.1406
As of 05/20/2013
* There is no guarantee that the issuers of the securities included in the portfolio will declare distributions in the future or that, if declared, they will either remain at current levels or increase over time.

 Holdings Analysis Click here to Perform a Benchmark Comparison  
 Sector Weighting
Consumer Discretionary  Consumer Discretionary 0.00%
Consumer Staples  Consumer Staples 0.00%
Energy  Energy 0.00%
Financials  Financials 0.00%
Health Care  Health Care 99.34%
Industrials  Industrials 0.00%
Information Technology  Information Technology 0.00%
Materials  Materials 0.00%
Telecommunication Services  Telecommunication Services 0.00%
Utilities  Utilities 0.00%
Other  Other 0.66%
 
  Large Mid Small  
Growth  47.34% 2.88% 0.00%  
Value  45.33% 3.79% 0.00%  

 Style Weighting
Large-Cap Growth 47.34%
Large-Cap Value 45.33%
Mid-Cap Growth 2.88%
Mid-Cap Value 3.79%
Small-Cap Growth 0.00%
Small-Cap Value 0.00%
Undetermined 0.66%
 Composition
U.S. Stocks 76.94%   Other 0.66%
Non-U.S. Stocks 22.40%      
The style and sector characteristics of the portfolio are determined as of 05/20/2013 and will likely vary thereafter due to market fluctuations in the underlying securities.  

 Holdings  Export Current Holdings | View Initial Holdings  
NameSymbolSectorStyleWeighting
 Gilead Sciences, Inc. GILD Health Care  Health Care Large-Cap Growth 5.17%
 Celgene Corporation CELG Health Care  Health Care Large-Cap Growth 4.60%
 Life Technologies Corporation LIFE Health Care  Health Care Large-Cap Value 4.28%
 Thermo Fisher Scientific Inc. TMO Health Care  Health Care Large-Cap Value 4.06%
 Valeant Pharmaceuticals International Inc. VRX Health Care  Health Care Large-Cap Growth 4.01%
 Universal Health Services, Inc. (Class B) UHS Health Care  Health Care Mid-Cap Value 3.79%
 Aetna Inc. AET Health Care  Health Care Large-Cap Value 3.75%
 Biogen Idec Inc. BIIB Health Care  Health Care Large-Cap Growth 3.75%
 Roche Holding AG (ADR) RHHBY Health Care  Health Care Large-Cap Growth 3.59%
 Sanofi (ADR) SNY Health Care  Health Care Large-Cap Value 3.50%
 Mylan, Inc. MYL Health Care  Health Care Large-Cap Growth 3.47%
 Vertex Pharmaceuticals Incorporated VRTX Health Care  Health Care Large-Cap Growth 3.43%
 AmerisourceBergen Corporation ABC Health Care  Health Care Large-Cap Growth 3.36%
 Novartis AG (ADR) NVS Health Care  Health Care Large-Cap Value 3.22%
 Johnson & Johnson JNJ Health Care  Health Care Large-Cap Growth 3.11%
 Stryker Corporation SYK Health Care  Health Care Large-Cap Value 3.10%
 Pfizer Inc. PFE Health Care  Health Care Large-Cap Value 3.07%
 Zimmer Holdings, Inc. ZMH Health Care  Health Care Large-Cap Value 3.05%
 McKesson Corporation MCK Health Care  Health Care Large-Cap Growth 3.02%
 Covidien Plc COV Health Care  Health Care Large-Cap Value 2.96%
 Varian Medical Systems, Inc. VAR Health Care  Health Care Mid-Cap Growth 2.88%
 St. Jude Medical, Inc. STJ Health Care  Health Care Large-Cap Growth 2.87%
 UnitedHealth Group Incorporated UNH Health Care  Health Care Large-Cap Value 2.69%
 Cardinal Health, Inc. CAH Health Care  Health Care Large-Cap Value 2.69%
 Shire Plc (ADR) SHPG Health Care  Health Care Large-Cap Growth 2.67%
 Merck & Co., Inc. MRK Health Care  Health Care Large-Cap Value 2.61%
 Allergan, Inc. AGN Health Care  Health Care Large-Cap Growth 2.60%
 Humana Inc. HUM Health Care  Health Care Large-Cap Value 2.52%
 Teva Pharmaceutical Industries Ltd. (ADR) TEVA Health Care  Health Care Large-Cap Value 2.45%
 AbbVie Inc. ABBV Health Care  Health Care Large-Cap Growth 1.69%
 Abbott Laboratories ABT Health Care  Health Care Large-Cap Value 1.38%
 
Total Number of Holdings:    31
Underlying Securities information represented above is as of 05/20/2013 but will vary with future fluctuations in the market.

An investment in an equity portfolio should be made with an understanding of the risks associated with an investment in common stocks including the risk that the financial condition of the issuers of the equities or the general condition of the stock market may worsen.

A portfolio which is concentrated in an individual sector is subject to additional risks, including limited diversification.

An investment in securities of foreign issuers should be made with an understanding of the additional risks involved, such as currency fluctuations, political risk, withholding, the lack of adequate financial information, and exchange control restrictions impacting foreign issuers.

The companies engaged in the health care sector are subject to fierce competition, high research and development costs, governmental regulations, loss of patent protection, and changing consumer spending trends. In addition, passage of the Health Care and Education Affordability Reconciliation Act of 2010, is expected to have significant implications for companies in the health care sector.

The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

All data used for the sector and style classification comparisons is from Bloomberg Finance L.P, which we believe to be reliable, but do not take responsibility for its accuracy.

The style and capitalization characteristics used to describe the stocks are designed to help you understand how they fit into your overall investment plan. Due to changes in the value of the stocks the characteristics may vary over time. In general, growth stocks have high relative price-to-book ratios while value stocks have low relative price-to-book ratios. In determining market capitalization characteristics, we analyze the market capitalizations of the 3,000 largest stocks in the U.S. (excluding foreign securities, ADRs, limited partnerships and regulated investment companies) on a monthly basis. Companies with market capitalizations among the largest 10% are considered Large-Cap securities, the next 20% are considered Mid-Cap securities and the remaining securities are considered Small-Cap securities.

You should carefully consider the trust's investment objectives, risks, and charges and expenses before investing. Contact your financial advisor or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the trust. Read it carefully before you invest.

This product information does not constitute an offer to sell, or a solicitation of an offer to buy securities in any state to any person to whom it is not lawful to make such an offer. Sales of any of these securities must include prospectus delivery and the services of a retail broker/dealer duly licensed in the appropriate states.

Not FDIC Insured, Not Bank Guaranteed and May Lose Value.

Printer Friendly Page Printer Friendly Page

 
First Trust Portfolios L.P.  Member SIPC and FINRA.
First Trust Advisors L.P.
Home |  Important Legal Information |  Privacy Policy |  Business Continuity Plan
Copyright © 2013 All rights reserved.